Anker Lundemose is the founder of MISSION Therapeutics. MISSION Therapeutics has raised $114M in total funding. Latest round: Series A.
Dr. Anker Lundemose is the Chief Executive Officer of MISSION Therapeutics, a clinical-stage biotech that develops therapeutics to enhance mitophagy for treating diseases such as Parkinson's and Acute Kidney Injury. He was appointed CEO of MISSION Therapeutics, and also serves as a Non-Executive Director at IsomAb.
Full founder directory · Investor directory · Company funding database · Fundraising library